Skip to main content
NYSE:NXU

Novus Capital Co. II Competitors

$9.73
0.00 (0.00 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.70
$9.73
50-Day Range N/A
52-Week Range
$9.58
$10.15
Volume47,110 shs
Average Volume37,915 shs
Market Capitalization$349.68 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Novus Capital Co. II (NYSE:NXU) Vs. AJAX, AJAX, PNTM, VSPR, BOAC, and BOWX

Should you be buying NXU stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Novus Capital Co. II, including Ajax I (AJAX), Ajax I (AJAX), Pontem (PNTM), Vesper Healthcare Acquisition (VSPR), Bluescape Opportunities Acquisition (BOAC), and BowX Acquisition (BOWX).

Ajax I (NYSE:AJAX) and Novus Capital Co. II (NYSE:NXU) are both small-cap unclassified companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

Profitability

This table compares Ajax I and Novus Capital Co. II's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Novus Capital Co. IIN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for Ajax I and Novus Capital Co. II, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Novus Capital Co. II0000N/A

Earnings and Valuation

This table compares Ajax I and Novus Capital Co. II's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Novus Capital Co. IIN/AN/AN/AN/AN/A

Ajax I (NYSE:AJAX) and Novus Capital Co. II (NYSE:NXU) are both small-cap unclassified companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

Profitability

This table compares Ajax I and Novus Capital Co. II's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Novus Capital Co. IIN/AN/AN/A

Earnings and Valuation

This table compares Ajax I and Novus Capital Co. II's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Novus Capital Co. IIN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for Ajax I and Novus Capital Co. II, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Novus Capital Co. II0000N/A

Pontem (NYSE:PNTM) and Novus Capital Co. II (NYSE:NXU) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings.

Earnings & Valuation

This table compares Pontem and Novus Capital Co. II's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PontemN/AN/AN/AN/AN/A
Novus Capital Co. IIN/AN/AN/AN/AN/A

Profitability

This table compares Pontem and Novus Capital Co. II's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PontemN/AN/AN/A
Novus Capital Co. IIN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Pontem and Novus Capital Co. II, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pontem0000N/A
Novus Capital Co. II0000N/A

Novus Capital Co. II (NYSE:NXU) and Vesper Healthcare Acquisition (NASDAQ:VSPR) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, earnings, profitability, valuation, risk, institutional ownership and dividends.

Analyst Ratings

This is a summary of current ratings and target prices for Novus Capital Co. II and Vesper Healthcare Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Novus Capital Co. II0000N/A
Vesper Healthcare Acquisition00203.00

Vesper Healthcare Acquisition has a consensus price target of $15.75, indicating a potential upside of 16.58%. Given Vesper Healthcare Acquisition's higher probable upside, analysts clearly believe Vesper Healthcare Acquisition is more favorable than Novus Capital Co. II.

Earnings and Valuation

This table compares Novus Capital Co. II and Vesper Healthcare Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novus Capital Co. IIN/AN/AN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Novus Capital Co. II and Vesper Healthcare Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Novus Capital Co. IIN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/A

Summary

Vesper Healthcare Acquisition beats Novus Capital Co. II on 2 of the 2 factors compared between the two stocks.

Bluescape Opportunities Acquisition (NYSE:BOAC) and Novus Capital Co. II (NYSE:NXU) are both small-cap unclassified companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Bluescape Opportunities Acquisition and Novus Capital Co. II, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bluescape Opportunities Acquisition0000N/A
Novus Capital Co. II0000N/A

Earnings & Valuation

This table compares Bluescape Opportunities Acquisition and Novus Capital Co. II's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A
Novus Capital Co. IIN/AN/AN/AN/AN/A

Profitability

This table compares Bluescape Opportunities Acquisition and Novus Capital Co. II's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bluescape Opportunities AcquisitionN/AN/AN/A
Novus Capital Co. IIN/AN/AN/A

BowX Acquisition (NASDAQ:BOWX) and Novus Capital Co. II (NYSE:NXU) are both small-cap unclassified companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for BowX Acquisition and Novus Capital Co. II, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BowX Acquisition0000N/A
Novus Capital Co. II0000N/A

Earnings & Valuation

This table compares BowX Acquisition and Novus Capital Co. II's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BowX AcquisitionN/AN/AN/AN/AN/A
Novus Capital Co. IIN/AN/AN/AN/AN/A

Profitability

This table compares BowX Acquisition and Novus Capital Co. II's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BowX AcquisitionN/AN/AN/A
Novus Capital Co. IIN/AN/AN/A


Novus Capital Co. II Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$9.91flat$886.38 millionN/A0.00
Ajax I logo
AJAX
Ajax I
0.0$9.91flat$886.38 millionN/A0.00
PNTM
Pontem
0.0$9.73flat$839.21 millionN/A0.00
Vesper Healthcare Acquisition logo
VSPR
Vesper Healthcare Acquisition
1.5$13.51flat$776.83 millionN/A0.00Gap Down
BOAC
Bluescape Opportunities Acquisition
0.0$9.86flat$748.75 millionN/A0.00
BOWX
BowX Acquisition
0.0$12.38flat$747.44 millionN/A0.00Unusual Options Activity
News Coverage
BTWN
Bridgetown
0.0$10.02flat$745.23 millionN/A0.00
VYGG
Vy Global Growth
0.0$9.90flat$711.56 millionN/A0.00
LGAC
Lazard Growth Acquisition Corp. I
0.0$9.72flat$698.63 millionN/A0.00News Coverage
LCY
Landcadia Holdings III
1.7$10.79flat$694.61 millionN/A0.00Analyst Revision
News Coverage
Gap Down
HZON
Horizon Acquisition Co. II
0.0$10.09flat$668.91 millionN/A0.00
ASZ
Austerlitz Acquisition Co. II
0.0$9.77flat$628.68 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$14.14flat$618.63 millionN/A0.00Gap Down
ACIC
Atlas Crest Investment
0.0$9.87flat$616.88 millionN/A0.00
CMLF
CM Life Sciences
0.0$11.13flat$615.98 millionN/A0.00Unusual Options Activity
News Coverage
MIT
Mason Industrial Technology
0.0$9.70flat$606.25 millionN/A0.00News Coverage
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.19flat$573.19 millionN/A0.00
VAQC
Vector Acquisition Co. II
0.0$9.95flat$570.63 millionN/A0.00News Coverage
KVSC
Khosla Ventures Acquisition Co. III
0.0$9.99flat$562.44 millionN/A0.00
GSEV
Gores Holdings VII
0.0$9.93flat$559.85 millionN/A0.00News Coverage
HAAC
Health Assurance Acquisition
0.0$10.05flat$556.52 millionN/A0.00News Coverage
MUDS
Mudrick Capital Acquisition Co. II
0.0$13.79flat$545.13 millionN/A0.00Gap Down
MAAC
Montes Archimedes Acquisition
0.0$9.86flat$518.36 millionN/A0.00
NGAB
Northern Genesis Acquisition Corp. II
0.0$9.82flat$508.19 millionN/A0.00
MOTV
Motive Capital
0.0$9.79flat$506.63 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.79flat$506.63 millionN/A0.00
DGNU
Dragoneer Growth Opportunities Corp. III
0.0$10.00flat$500 millionN/A0.00News Coverage
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.74flat$498.82 millionN/A0.00
Supernova Partners Acquisition logo
SPNV
Supernova Partners Acquisition
0.0$9.90flat$497.85 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.74flat$497.83 millionN/A0.00News Coverage
GMII
Gores Metropoulos II
0.0$9.89flat$494.50 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.75flat$490.55 millionN/A0.00
NSTD
Northern Star Investment Corp. IV
0.0$9.80flat$490 millionN/A0.00High Trading Volume
SRNG
Soaring Eagle Acquisition
0.0$9.90flat$489.92 millionN/A0.00High Trading Volume
News Coverage
DCRN
Decarbonization Plus Acquisition Co. II
0.0$9.69flat$487.53 millionN/A0.00
NGAC
NextGen Acquisition
0.0$9.88flat$463.13 millionN/A0.00
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.04flat$462.84 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$10.28flat$462.60 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.81flat$446.29 millionN/A0.00
LUXA
Lux Health Tech Acquisition
0.0$10.04flat$432.98 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.91flat$427.37 millionN/A0.00News Coverage
SPFR
Jaws Spitfire Acquisition
0.0$9.91flat$427.37 millionN/A0.00
RMGB
RMG Acquisition Co. II
0.0$9.86flat$425.21 millionN/A0.00
ACII
Atlas Crest Investment Corp. II
0.0$9.76flat$420.90 millionN/A0.00
DHHC
DiamondHead
0.0$9.75flat$420.47 millionN/A0.00
KURI
Alkuri Global Acquisition
0.0$9.72flat$419.18 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$9.70flat$418.31 millionN/A0.00
CBAH
CBRE Acquisition
0.0$9.76flat$412.49 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.50flat$411.75 millionN/A0.00
NSTB
Northern Star Investment Corp. II
0.0$9.90flat$396 millionN/A0.00
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.